课题基金 / 基金详情

Pharmacogenetic analysis of rivastigmine response in Lewy body spectrum disorders: Clinical and brain SPECT correlates

Pharmacogenetic analysis of rivastigmine response in Lewy body spectrum disorders: Clinical and brain SPECT correlates
路易体谱系疾病卡巴拉汀反应的药物遗传学分析：临床和脑 SPECT 相关性
批准号：
197060
负责人：
Masellis Mario
金额：
$4.19万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2010-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=197060&lang=en
关键词：
Genetic Association Study Lewy Body Disease Neuropsychological Testing Pharmacodynamic Pharmacogenetics Pharmacokinetic Polygenic Polymorphism Rivastigmine Spect

项目摘要

项目成果

Masellis Mario的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dementia with Lewy Bodies (DLB) and Parkinson¿s Disease with Dementia (PDD) are common neurodegenerative disorders which cause significant disability, reduced quality of life and eventually death in the elderly. Treatment with drugs known as cholinesteras
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TACKLing the challenges of PREsymptomatic sporadic Dementia (TACKL-PRED)
NeuroCovid: European Solution for the Global Problem of dementia and Neurodegeneration following COVID-19 (EU-Connect)
  • 批准号：
    467283
  • 项目类别：
    Operating Grants
  • 资助金额：
    $0.0万
  • 财政年份：
    2021
  • 负责人：
    Masellis Mario
  • 依托单位：
    University of Toronto
Genetic Frontotemporal Dementia Initiative (GENFI) in Canada: Combined Investigation of Clinical, MRI, Genomic, and Epigenomic Biomarkers
Mid Career Investigator Prize in Research in Aging: Genetic Frontotemporal Dementia Initiative (GENFI) in Canada: Combined Investigation of Clinical, MRI, Genomic, and Epigenomic Biomarkers
海外基金